Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
17.33
-0.17 (-0.97%)
Jul 11, 2025, 9:51 AM - Market open
Immunovant Market Cap
Immunovant has a market cap or net worth of $2.96 billion as of July 11, 2025. Its market cap has decreased by -25.84% in one year.
Market Cap
2.96B
Enterprise Value
2.28B
1-Year Change
-25.84%
Ranking
Category
Stock Price
$17.33
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $2.96B, an increase of 2,283.62%. That is a compound annual growth rate of 68.79%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.79B |
| Johnson & Johnson | 379.41B |
| AbbVie | 344.45B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 271.70B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 223.49B |